Circulating visfatin level at admission is associated with occlusion of the infarct-related artery in patients with acute ST-segment elevation myocardial infarction

Acta Cardiologica Sinica

Volumn 27, Issue 2, 2011, Pages 77-85

  Yu, Teng Hung ^a   Lu, Li Fen ^a   Hung, Wei Chin ^a   Chiu, Cheng An ^a   Liu, Yi Tien ^a   Yang, Chih Ying ^a   Tsai, I Ting ^a   Yen, Yung Chieh ^a   Chen, Chih Yu ^a   Wang, Chao Ping ^a  

^a I SHOU UNIVERSITY   (Taiwan)

Author keywords

Acute ST segment elevation myocardial infarction; Occlusion of the infarct related artery; Visfatin

Indexed keywords

C REACTIVE PROTEIN; CREATINE KINASE MB; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; ANGIOPLASTY; ARTERY OCCLUSION; ARTICLE; BLOOD PRESSURE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 80052186956     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Jeremy RW, Hackworthy RA, Bautovich G, et al. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. J Am Coll Cardiol 1987;9: 989-95. (Pubitemid 17065754)
2. Pfeffer MA, Lamas GA, Vaughan DE, et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-6.
3. Sager PT, Perlmutter RA, Rosenfeld LE, et al. Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation. J Am Coll Cardiol 1988;12:19-24.
4. Samal B, Sun Y, Stearns G, et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994;14:1431-7.
5. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005;307:426-30. (Pubitemid 40139988)
6. Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006;91:295-9.
7. Bertolani C, Marra F. The role of adipokines in liver fibrosis. Pathophysiology 2008;15:91-101.
8. Axelsson J, Witasp A, Carrero JJ, et al. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Am J Kidney Dis 2007;49:237-44. (Pubitemid 46178402)
9. Luk T, Malam Z, Marshall JC. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 2008;83:804-16. (Pubitemid 351959859)
10. Takebayashi K, Suetsugu M, Wakabayashi S, et al. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 2007;56: 451-8. (Pubitemid 46427838)
11. Dahl TB, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization. Circulation 2007;115:972-80. (Pubitemid 46328290)
12. Liu SW, Qiao SB, Yuan JS, Liu DQ. Association of plasma visfatin levels with inflammation, atherosclerosis, and acute coronary syndromes in humans. Clin Endocrinol (Oxf) 2009;71: 202-7.
13. Lim SY, Davidson SM, Paramanathan AJ, et al. The novel adipocytokine visfatin exerts direct cardioprotective effects. J Cell Mol Med 2008;12:1395-403.
14. Krzysik-Walker SM, Ocón-Grove OM, Maddineni SR, et al. Is visfatin an adipokine or myokine? Evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens. Endocrinology 2008;149:1543-50. (Pubitemid 351468312)
15. Walsh K. Adipokines, myokines and cardiovascular disease. Circ J 2009;73:13-8.
16. Chung FM, Tsai JCR, Chang DM, et al. Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis. Diabetes Care 2005;28: 1710-7.
17. Estévez-Loureiro R, Salgado-Fernández J, Marzoa-Rivas R, et al. Mean platelet volume predicts patency of the infarct-related artery before mechanical reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Thromb Res 2009;124:536-40.
18. Lai FJ, Hsieh MC, Hsin SC, et al. The cellular localization of increased atrial natriuretic peptide mRNA and immunoreactivity in diabetic rat kidneys. J Histochem Cytochem 2002;50:1501-8.
19. van der Veer E, Nong Z, O'Neil C, et al. Pre-B-cell colony-enhancing factor regulates NAD+-dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res 2005;97:25-34. (Pubitemid 40982319)
20. White HD, Norris RM, Brown MA, et al. Left ventricular endsystolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51. (Pubitemid 17093191)
21. Pinto DS, Kirtane AJ, Pride YB, et al. CLARITY-TIMI 28 Investigators. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). Am J Cardiol 2008;101:303-7. (Pubitemid 351162961)
22. Maden O, Kacmaz F, Selcuk MT, et al. Relationship of admission haematological indices with infarct-related artery patency in patients with acute ST-segment elevation myocardial infarction treated with primary angioplasty. Coron Artery Dis 2007;18: 639-44. (Pubitemid 351339518)
23. Abbate A, Bussani R, Biondi-Zoccai GG, et al. Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. Eur Heart J 2005;26:2039-45. (Pubitemid 41435731)
24. Barron HV, Cannon CP, Murphy SA, et al. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 2000;102:2329-34.
25. Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 2007;23:164-70. (Pubitemid 46192971)
26. Moschen AR, Kaser A, Enrich B, et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007;178:1748-58. (Pubitemid 46154646)
27. Ognjanovic S, Bao S, Yamamoto SY, et al. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001;26:107-17. (Pubitemid 32266186)
28. Jia SH, Li Y, Parodo J, et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004;113:1318-27. (Pubitemid 39069931)
29. Sethi JK, Vidal-Puig A. Visfatin: the missing link between intraabdominal obesity and diabetes? Trends Mol Med 2005;11:344-7.
30. Tardiff BE, Califf RM, Tcheng JE, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II. J Am Coll Cardiol 1999;33:88-96.